Bariatric Surgery: Latest News
American Heart Association (AHA) endorses Weight-Loss Surgery for severely obese individuals
In its first focused look at bariatric surgery, the American Heart Association (AHA) said the procedure is appropriate for reducing cardiac risk factors in certain groups of severely obese individuals.
In a new scientific statement, the AHA provides a comprehensive and balanced overview of the effects of bariatric surgery on cardiovascular risk factors including hypertension, dysplipidaemia, diabetes, fatty liver disease and obstructive sleep apnoea.
The AHA comments that:
  • Although diet, exercise and behavior modification (ie non-surgical treatment) are mainstay therapy for overweight and obesity, they are disappointingly unsuccessful for long-term treatment of severe obesity.
  • Strategies should be developed for better long-term weight management of patients and bariatric surgery is certainly a viable option today.
  • Bariatric surgery significantly reduces the risks of premature death from cardiovascular and non-cardiovascular complications of severe obesity.
  • Weight loss following bariatric surgery has proven benefit on cardiac morphology and function. Other benefits include resolution or improvement in control of obesity-related conditions such as hypertension, diabetes, dyslipidaemia, sleep apnoea and fatty liver disease.
Click here for a copy of this document: 'Bariatric Surgery and Cardiovascular Risk Factors: A Scientific Statement From the American Heart Association'

Bariatric Surgery: Latest News
U.S. Food and Drug Administration expands indications for use of gastric banding system for weight loss
International Diabetes Federation (IDF) announces that bariatric surgery is an appropriate treatment for obese people with Type 2 diabetes
American Heart Association (AHA) endorses Weight-Loss Surgery for severely obese individuals
STAMPEDE trial (Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently) shows that surgical therapy beats standard medical therapy in obese patients with Type 2 Diabetes